A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer
Kumiko Kida, Akimitsu Yamada, Kazuhiro Shimada, Kazutaka Narui, Sadatoshi Sugae, Daisuke Shimizu, Takako Doi, Mari S. Oba, Itaru Endo, Takashi Ishikawa
Topics & Concepts
MedicinePaclitaxelTaxaneBreast cancerOncologyPeripheral neuropathySurgical oncologyInternal medicineProspective cohort studyCancerChemotherapy-induced peripheral neuropathyDiabetes mellitusEndocrinologyCancer Treatment and PharmacologyCancer-related cognitive impairment studiesBreast Cancer Treatment Studies